Evidence-based feeding strategies before and after the development of necrotizing enterocolitis

References

• Henry MC, Moss RL. Necrotizing enterocolitis. Annu Rev Med 2009;60:111-24
   PubMed Web of Science ®Google Scholar
• Caplan MS, Jilling T. New concepts in necrotizing enterocolitis. Curr Opin Pediatr 2001;13(2):111-15
   Web of Science ®Google Scholar
• Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364(3):255-64
   PubMed Web of Science ®Google Scholar
• Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006;368(9543):1271-83
   PubMed Web of Science ®Google Scholar
• Kliegman RM, Walsh MC. Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr 1987;17(4):213-88
   PubMedGoogle Scholar
• Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187(1):1-7
   PubMed Web of Science ®Google Scholar
• Neu J. Neonatal necrotizing enterocolitis: an update. Acta Paediatr 2005;94(449):100-5
   Google Scholar
• Lee JS, Polin RA. Treatment and prevention of necrotizing enterocolitis. Semin Neonatol 2003;8(6):449-59
   PubMedGoogle Scholar
• Frantz ID 3rd, L’Heureux P, Engel RR, Hunt CE. Necrotizing enterocolitis. J Pediatr 1975;86(2):259-63
   Google Scholar
• Vollman JH, Smith WL, Tsang RC. Necrotizing enterocolitis with recurrent hepatic portal venous gas. J Pediatr 1976;88(3):486-7
   Google Scholar
• Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990;336(8730):1519-23
   PubMed Web of Science ®Google Scholar
• Newburg DS, Walker WA. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 2007;61(1):2-8
   PubMed Web of Science ®Google Scholar
• Meinzen-Derr J, Poindexter B, Wrage L, et al. Role of human milk in extremely low birth weight infants’ risk of necrotizing enterocolitis or death. J Perinatol 2009;29(1):57-62
   PubMed Web of Science ®Google Scholar
• Schanler RJ, Lau C, Hurst NM, Smith EO. Randomized trial of donor human milk versus preterm formula as substitutes for mothers’ own milk in the feeding of extremely premature infants. Pediatrics 2005;116(2):400-6
   PubMed Web of Science ®Google Scholar
• McGuire W, Anthony MY. Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review. Arch Dis Child Fetal Neonatal Ed 2003;88(1):F11-14
   PubMed Web of Science ®Google Scholar
• Quigley MA, Henderson G, Anthony MY, McGuire W. Formula milk versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 2007(4):CD002971
   Google Scholar
• Davies DP. Adequacy of expressed breast milk for early growth of preterm infants. Arch Dis Child 1977;52(4):296-301
   Google Scholar
• Gross SJ. Growth and biochemical response of preterm infants fed human milk or modified infant formula. N Engl J Med 1983;308(5):237-41
   Google Scholar
• Lucas A, Gore SM, Cole TJ, et al. Multicentre trial on feeding low birthweight infants: effects of diet on early growth. Arch Dis Child 1984;59(8):722-30
   Web of Science ®Google Scholar
• Lucas A, Morley R, Cole TJ, et al. Early diet in preterm babies and developmental status in infancy. Arch Dis Child 1989;64(11):1570-8
   Google Scholar
• Raiha NC, Heinonen K, Rassin DK, Gaull GE. Milk protein quantity and quality in low-birthweight infants: I. Metabolic responses and effects on growth. Pediatrics 1976;57(5):659-84
   PubMed Web of Science ®Google Scholar
• Schultz K, Soltesz G, Mestyan J. The metabolic consequences of human milk and formula feeding in premature infants. Acta Paediatr Scand 1980;69(5):647-52
   Google Scholar
• Tyson JE, Lasky RE, Mize CE, et al. Growth, metabolic response, and development in very-low-birth-weight infants fed banked human milk or enriched formula. I. Neonatal findings. J Pediatr 1983;103(1):95-104
   Google Scholar
• Henderson G, Anthony MY, McGuire W. Formula milk versus maternal breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 2007(4):CD002972
   Google Scholar
• Cristofalo EA, Schanler RJ, Blanco CL, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr 2013;163(6):1592-5. e1591
   PubMed Web of Science ®Google Scholar
• Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 1999;103(6 Pt 1):1150-7
   Google Scholar
• Furman L, Taylor G, Minich N, Hack M. The effect of maternal milk on neonatal morbidity of very low-birth-weight infants. Arch Pediatr Adolesc Med 2003;157(1):66-71
   Google Scholar
• Jones JA, Ninnis JR, Hopper AO, et al. Nitrite and nitrate concentrations and metabolism in breast milk, infant formula, and parenteral nutrition. JPEN J Parenter Enteral Nutr 2013. [Epub ahed of print]
   Google Scholar
• Petersson J, Phillipson M, Jansson EA, et al. Dietary nitrate increases gastric mucosal blood flow and mucosal defense. Am J Physiol Gastrointest Liver Physiol 2007;292(3):G718-24
   Google Scholar
• Nankervis CA, Giannone PJ, Reber KM. The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis. Semin Perinatol 2008;32(2):83-91
   PubMed Web of Science ®Google Scholar
• Nankervis CA, Reber KM, Nowicki PT. Age-dependent changes in the postnatal intestinal microcirculation. Microcirculation 2001;8(6):377-87
   Google Scholar
• Duncan C, Dougall H, Johnston P, et al. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med 1995;1(6):546-51
   PubMed Web of Science ®Google Scholar
• Kanady JA, Aruni AW, Ninnis JR, et al. Nitrate reductase activity of bacteria in saliva of term and preterm infants. Nitric Oxide 2012;27(4):193-200
   Google Scholar
• Yazji I, Sodhi CP, Lee EK, et al. Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling. Proc Natl Acad Sci USA 2013;110(23):9451-6
   PubMed Web of Science ®Google Scholar
• Sodhi C, Richardson W, Gribar S, Hackam DJ. The development of animal models for the study of necrotizing enterocolitis. Dis Model Mech 2008;1(2-3):94-8
   PubMed Web of Science ®Google Scholar
• Polycarpou E, Zachaki S, Tsolia M, et al. Enteral L-arginine supplementation for prevention of necrotizing enterocolitis in very low birth weight neonates: a double-blind randomized pilot study of efficacy and safety. JPEN J Parenter Enteral Nutr 2013;37(5):617-22
   PubMed Web of Science ®Google Scholar
• Amin HJ, Zamora SA, McMillan DD, et al. Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr 2002;140(4):425-31
   PubMed Web of Science ®Google Scholar
• Polycarpou E, Zachaki S, Tsolia M, et al. Enteral L-arginine supplementation for prevention of necrotizing enterocolitis in very low birth weight neonates: a double-blind randomized pilot study of efficacy and safety. JPEN J Parenter Enteral Nutr 2013;37(5):617-22
   PubMed Web of Science ®Google Scholar
• Rhoads JM, Argenzio RA, Chen W, et al. L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol 1997;272(5 Pt 1):G943-53
   Google Scholar
• Poindexter BB, Ehrenkranz RA, Stoll BJ, et al. Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics 2004;113(5):1209-15
   PubMed Web of Science ®Google Scholar
• Becker RM, Wu G, Galanko JA, et al. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr 2000;137(6):785-93
   Google Scholar
• Pawlik D, Lauterbach R, Hurkala J, Radziszewska R. [The effects of enteral administration of glutamine enriched solution in very low birth weight infants on reducing the symptoms of feeding intolerance. A prospective, randomized pilot study]. Med Wieku Rozwoj 2012;16(3):205-11
   PubMedGoogle Scholar
• Moe-Byrne T, Wagner JV, McGuire W. Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012;3:CD001457
   PubMedGoogle Scholar
• Newburg DS. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 2009;87(13 Suppl):26-34
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Cervantes LE, Ramos P, et al. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem 2003;278(16):14112-20
   Google Scholar
• Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005;25:37-58
   PubMed Web of Science ®Google Scholar
• Bode L. Human milk oligosaccharides: prebiotics and beyond. Nutr Rev 2009;67(Suppl 2):S183-91
   PubMedGoogle Scholar
• Weng M, Walker WA. The role of gut microbiota in programming the immune phenotype. J Dev Orig Health Dis 2013;4:3
   Google Scholar
• Jantscher-Krenn E, Zherebtsov M, Nissan C, et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut 2012;61(10):1417-25
   PubMed Web of Science ®Google Scholar
• Valenti P, Antonini G. Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 2005;62(22):2576-87
   PubMed Web of Science ®Google Scholar
• Haversen L, Ohlsson BG, Hahn-Zoric M, et al. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol 2002;220(2):83-95
   PubMed Web of Science ®Google Scholar
• Buccigrossi V, de Marco G, Bruzzese E, et al. Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res 2007;61(4):410-14
   PubMed Web of Science ®Google Scholar
• Sherman MP, Bennett SH, Hwang FF, Yu C. Neonatal small bowel epithelia: enhancing anti-bacterial defense with lactoferrin and Lactobacillus GG. Biometals 2004;17(3):285-9
   PubMed Web of Science ®Google Scholar
• Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009;302(13):1421-8
   PubMed Web of Science ®Google Scholar
• Magnuson JS, Henry JF, Yip TT, Hutchens TW. Structural homology of human, bovine, and porcine milk lactoferrins: evidence for shared antigenic determinants. Pediatr Res 1990;28(2):176-81
   PubMed Web of Science ®Google Scholar
• Dvorak B. Milk epidermal growth factor and gut protection. J Pediatr 2010;156(2 Suppl):S31-5
   Google Scholar
• Nair RR, Warner BB, Warner BW. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis. Semin Perinatol 2008;32(2):107-13
   Google Scholar
• Feng J, Besner GE. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis. J Pediatr Surg 2007;42(1):214-20
   PubMedGoogle Scholar
• Sheng G, Bernabe KQ, Guo J, Warner BW. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression. Gastroenterology 2006;131(1):153-64
   Google Scholar
• Pollack PF, Goda T, Colony PC, et al. Effects of enterally fed epidermal growth factor on the small and large intestine of the suckling rat. Regul Pept 1987;17(3):121-32
   Google Scholar
• Dvorak B, Williams CS, McWilliam DL, et al. Milk-borne epidermal growth factor modulates intestinal transforming growth factor-alpha levels in neonatal rats. Pediatr Res 2000;47(2):194-200
   Google Scholar
• Clark JA, Doelle SM, Halpern MD, et al. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 2006;291(5):G938-49
   PubMed Web of Science ®Google Scholar
• Dvorak B, Halpern MD, Holubec H, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002;282(1):G156-64
   PubMed Web of Science ®Google Scholar
• Clark JA, Lane RH, Maclennan NK, et al. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005;288(4):G755-62
   Google Scholar
• Yu X, Radulescu A, Zorko N, Besner GE. Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis. Gastroenterology 2009;137(1):221-30
   PubMedGoogle Scholar
• Dvorak B, Khailova L, Clark JA, et al. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 2008;47(1):11-18
   Google Scholar
• Morgan J, Bombell S, McGuire W. Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants. Cochrane Database Syst Rev 2013;3:CD000504
   Google Scholar
• McClure RJ, Newell SJ. Randomised controlled study of clinical outcome following trophic feeding. Arch Dis Child Fetal Neonatal Ed 2000;82(1):F29-33
   PubMed Web of Science ®Google Scholar
• Sallakh-Niknezhad A, Bashar-Hashemi F, Satarzadeh N, et al. Early versus Late Trophic Feeding in Very Low Birth Weight Preterm Infants. Iran J Pediatr 2012;22(2):171-6
   PubMed Web of Science ®Google Scholar
• Berseth CL, Bisquera JA, Paje VU. Prolonging small feeding volumes early in life decreases the incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2003;111(3):529-34
   PubMed Web of Science ®Google Scholar
• Morgan J, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev 2013;3:CD001241
   PubMedGoogle Scholar
• Rayyis SF, Ambalavanan N, Wright L, Carlo WA. Randomized trial of "slow" versus "fast" feed advancements on the incidence of necrotizing enterocolitis in very low birth weight infants. J Pediatr 1999;134(3):293-7
   Web of Science ®Google Scholar
• Caple J, Armentrout D, Huseby V, et al. Randomized, controlled trial of slow versus rapid feeding volume advancement in preterm infants. Pediatrics 2004;114(6):1597-600
   Web of Science ®Google Scholar
• Salhotra A, Ramji S. Slow versus fast enteral feed advancement in very low birth weight infants: a randomized control trial. Indian Pediatr 2004;41(5):435-41
   PubMedGoogle Scholar
• Krishnamurthy S, Gupta P, Debnath S, Gomber S. Slow versus rapid enteral feeding advancement in preterm newborn infants 1000-1499 g: a randomized controlled trial. Acta Paediatr 2010;99(1):42-6
   Web of Science ®Google Scholar
• Karagol BS, Zenciroglu A, Okumus N, Polin RA. Randomized controlled trial of slow vs rapid enteral feeding advancements on the clinical outcomes of preterm infants with birth weight 750-1250 g. JPEN J Parenter Enteral Nutr 2013;37(2):223-8
   PubMed Web of Science ®Google Scholar
• Maas C, Mitt S, Full A, et al. A historic cohort study on accelerated advancement of enteral feeding volumes in very premature infants. Neonatology 2013;103(1):67-73
   Web of Science ®Google Scholar
• Stephens BE, Walden RV, Gargus RA, et al. First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics 2009;123(5):1337-43
   PubMed Web of Science ®Google Scholar
• Kuschel CA, Harding JE. Multicomponent fortified human milk for promoting growth in preterm infants. Cochrane Database Syst Rev 2004(1):CD000343
   Google Scholar
• Thoene M, Hanson C, Lyden E, et al. Comparison of the effect of two human milk fortifiers on clinical outcomes in premature infants. Nutrients 2014;6(1):261-75
   Google Scholar
• FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. In: Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada: 2002
   Google Scholar
• Indian Council of Medical Research Task F; Co-ordinating Unit I; Co-ordinating Unit DBT. ICMR-DBT guidelines for evaluation of probiotics in food. Indian J Med Res 2011;134:22-5
   Google Scholar
• Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115(1):1-4
   PubMed Web of Science ®Google Scholar
• Dani C, Biadaioli R, Bertini G, et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002;82(2):103-8
   PubMedGoogle Scholar
• Li D, Rosito G, Slagle T. Probiotics for the prevention of necrotizing enterocolitis in neonates: an 8-year retrospective cohort study. J Clin Pharm Ther 2013;38(6):445-9
   Google Scholar
• Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147(2):192-6
   PubMed Web of Science ®Google Scholar
• Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011(3):CD005496
   Google Scholar
• Wang Q, Dong J, Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg 2012;47(1):241-8
   PubMed Web of Science ®Google Scholar
• Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006;42(12):1735-42
   PubMed Web of Science ®Google Scholar
• Braga TD, da Silva GA, de Lira PI, de Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr 2011;93(1):81-6
   Google Scholar
• Alfaleh K, Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2008(1):CD005496
   Google Scholar
• Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007;369(9573):1614-20
   PubMed Web of Science ®Google Scholar
• Mally P, Golombek SG, Mishra R, et al. Association of necrotizing enterocolitis with elective packed red blood cell transfusions in stable, growing, premature neonates. Am J Perinatol 2006;23(8):451-8
   PubMed Web of Science ®Google Scholar
• Mohamed A, Shah PS. Transfusion associated necrotizing enterocolitis: a meta-analysis of observational data. Pediatrics 2012;129(3):529-40
   PubMed Web of Science ®Google Scholar
• El-Dib M, Narang S, Lee E, et al. Red blood cell transfusion, feeding and necrotizing enterocolitis in preterm infants. J Perinatol 2011;31(3):183-7
   PubMed Web of Science ®Google Scholar
• Kastenberg ZJ, Sylvester KG. The surgical management of necrotizing enterocolitis. Clin Perinatol 2013;40(1):135-48
   Web of Science ®Google Scholar
• Stringer MD, Brereton RJ, Drake DP, et al. Recurrent necrotizing enterocolitis. J Pediatr Surg 1993;28(8):979-81
   Google Scholar
• Thyoka M, Eaton S, Hall NJ, et al. Advanced necrotizing enterocolitis part 2: recurrence of necrotizing enterocolitis. Eur J Pediatr Surg 2012;22(1):13-16
   PubMed Web of Science ®Google Scholar
• Bohnhorst B, Muller S, Dordelmann M, et al. Early feeding after necrotizing enterocolitis in preterm infants. J Pediatr 2003;143(4):484-7
   Google Scholar
• Grave GD, Nelson SA, Walker WA, et al. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop. Pediatr Res 2007;62(4):510-14
   Google Scholar
• Leaphart CL, Cavallo J, Gribar SC, et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 2007;179(7):4808-20
   PubMed Web of Science ®Google Scholar
• Jilling T, Simon D, Lu J, et al. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol 2006;177(5):3273-82
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Nahmias AJ, Wickliffe C, et al. Bacterial toxin and neonatal necrotizing enterocolitis. J Pediatr 1980;96(1):114-15
   Google Scholar
• Nanthakumar N, Meng D, Goldstein AM, et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS One 2011;6(3):e17776
   PubMed Web of Science ®Google Scholar
• Wolfs TG, Derikx JP, Hodin CM, et al. Localization of the lipopolysaccharide recognition complex in the human healthy and inflamed premature and adult gut. Inflamm Bowel Dis 2010;16(1):68-75
   Web of Science ®Google Scholar
• Chan KL, Wong KF, Luk JM. Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: pathogenesis and therapeutic implications. World J Gastroenterol 2009;15(38):4745-52
   Google Scholar
• Richardson WM, Sodhi CP, Russo A, et al. Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium. Gastroenterology 2010;139(3):904-17. 917 e901-906
   Google Scholar
• Sodhi CP, Shi XH, Richardson WM, et al. Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology 2010;138(1):185-96
   PubMed Web of Science ®Google Scholar
• Sodhi CP, Neal MD, Siggers R, et al. Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology 2012;143(3):708-18. e701-705
   PubMed Web of Science ®Google Scholar
• Gribar SC, Sodhi CP, Richardson WM, et al. Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol 2009;182(1):636-46
   PubMed Web of Science ®Google Scholar
• Neal MD, Jia H, Eyer B, et al. Discovery and validation of a new class of small molecule Toll-like receptor 4 (TLR4) inhibitors. PLoS One 2013;8(6):e65779
   Google Scholar
• Good M, Siggers RH, Sodhi CP, et al. Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium. Proc Natl Acad Sci USA 2012;109(28):11330-5
   PubMed Web of Science ®Google Scholar
• Siggers J, Ostergaard MV, Siggers RH, et al. Postnatal amniotic fluid intake reduces gut inflammatory responses and necrotizing enterocolitis in preterm neonates. Am J Physiol Gastrointest Liver Physiol 2013;304(10):G864-75
   PubMed Web of Science ®Google Scholar
• Jain SK, Baggerman EW, Mohankumar K, et al. Amniotic fluid-borne hepatocyte growth factor protects rat pups against experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2014;306(5):G361-9
   PubMed Web of Science ®Google Scholar